2. Search Result
Search Result
Results for "

Osimertinib-<sup>13</sup>C,d<sub>3</sub>

" in MedChemExpress (MCE) Product Catalog:
Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-15772S1
    Osimertinib-13C,d3

    AZD-9291-<sup>13sup>C,d<sub>3sub>; Mereletinib-<sup>13sup>C,d<sub>3sub>

    		 EGFR Cancer
    Osimertinib- 13C,d3 is the deuterium and 13C labeled Osimertinib. Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively.
    Osimertinib-13C,d3